|
|
Volumn 339, Issue , 2009, Pages
|
|
GlaxoSmithKline told to pay family $2.5m after jury finds paroxetine caused son's heart defects.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIDEPRESSANT AGENT;
PAROXETINE;
CHEMICALLY INDUCED DISORDER;
COMPENSATION;
CONGENITAL HEART MALFORMATION;
DEPRESSION;
DRUG INDUSTRY;
ECONOMICS;
FEMALE;
HUMAN;
LEGAL ASPECT;
MALE;
NOTE;
PREGNANCY;
PREGNANCY COMPLICATION;
PRESCHOOL CHILD;
UNITED STATES;
ANTIDEPRESSIVE AGENTS, SECOND-GENERATION;
CHILD, PRESCHOOL;
COMPENSATION AND REDRESS;
DEPRESSIVE DISORDER;
DRUG INDUSTRY;
FEMALE;
HEART DEFECTS, CONGENITAL;
HUMANS;
MALE;
PAROXETINE;
PHILADELPHIA;
PREGNANCY;
PREGNANCY COMPLICATIONS;
|
|
EID: 70350441301
PISSN: None
EISSN: 14685833
Source Type: Journal
DOI: 10.1136/bmj.b4266 Document Type: Note |
|
Times cited : (5)
|
|
References (0)
|
